Moreover, PTPRO-mediated autophagy inhibits tumorigenesis in hepatocellular carcinoma (HCC) [17], and PTPRO downregulation is associated with an IL-6-driven increase in PD-L1 expression in monocytes and macrophages [18]. Here, IL6 is linked to hepatocellular carcinoma.